The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study
Open accessAbstract
The central nervous system has the second highest concentration of lipids after adipose tissue. Alterations in neural membrane phospho- and sphingolipid composition can influence crucial intra- and intercellular signalling and alter the membrane's properties. Recently, the polyunsaturated fatty acids (PUFA) hypothesis for depression suggests that phospho- and sphingolipid metabolism includes potential pathways for the disease. In 742 people from a Dutch family-based study, we assessed the relationships between 148 different plasma phospho- and sphingolipid species and depression/anxiety symptoms as measured by the Hospital Anxiety and Depression Scales (HADS-A and HADS-D) and the Centre for Epidemiological Studies Depression Scale (CES-D). We observed significant differences in plasma sphingomyelins (SPM), particularly the SPM 23:1/SPM 16:0 ratio, which was inversely correlated with depressive symptom scores. We observed a similar trend for plasma phosphatidylcholines (PC), particularly the molar proportion of PC O 36:4 and its ratio to ceramide CER 20:0. Absolute levels of PC O 36:4 were also associated with depression symptoms in an independent replication. To our knowledge this is the first study on depressive symptoms that focuses on specific phospho- and sphingolipid molecules in plasma rather than total PUFA concentrations. The findings of this lipidomic study suggests that plasma sphingomyelins and ether phospholipids should be further studied for their potential as biomarkers and for a better understanding of the underlying mechanisms of this systemic disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have indicated an association between the lipid concentrations of octadecyl-phosphatidylethanolamine (PE-O) [58], SM, and PC-O [63] and symptom severity according to the specific scales.”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [63]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 1×
“Several validation studies on various types of patients using different diagnostic tools have shown that HADS performs well in assessing symptom severity and case status for anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population (Bjelland et al., 2002).”
MethodMultipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L. A., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,021
Fisher, R. A. (1915) · Biometrika · doi:10.1093/biomet/10.4.507 · Cited by 2,230
Fisher, R. A. (1915) · Biometrika · doi:10.2307/2331838 · Cited by 1,334
Beekman, A. T. F., Deeg, D. J. H., van Limbeek, J., Braam, A. W., VRIES, M. Z. D., & van Tilburg, W. (1997) · Psychological Medicine · doi:10.1017/s0033291796003510 · Cited by 1,135
Brügger, B., Erben, G., Sandhoff, R., Wieland, F., & Lehmann, W. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2339 · Cited by 882
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555
Handbook of clinical neurology
Munsat, T. L. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90014-b · Cited by 552
Cited by
Sorted by citations
Brain membrane lipids in major depression and anxiety disorders
Müller, C. P., Reichel, M., Mühle, C., Rhein, C., Gulbins, E., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.014 · Cited by 308
“amined persons with other types of disorders that also had depressive symptoms [46,83,144].”
BackgroundAntidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
Gulbins, A., Schumacher, F., Becker, K. A., Wilker, B., Soddemann, M., Boldrin, F., Müller, C. P., Edwards, M. J., Goodman, M. D., Caldwell, C. C., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0090-9 · Cited by 230
Analytical Methods in Lipidomics and Their Applications
Li, M., Li, Y., Bai, Y., & Liu, H. (2013) · Analytical Chemistry · doi:10.1021/ac403554h · Cited by 220
Gadad, B. S., Jha, M. K., Czysz, A., Furman, J. L., Mayes, T. L., Emslie, M. P., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.001 · Cited by 205
“Most notably the ratio of sphingomyelin 23:1 to sphingomyelin 16:0 was inversely related to depression severity (Demirkan et al., 2013).”
BackgroundRegulation of sphingomyelin metabolism
Bienias, K., Fiedorowicz, A., Sadowska, A. J., Prokopiuk, S., & Car, H. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2015.12.008 · Cited by 199
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“The sphingomyelin 23:1 to sphingomyelin 16:0 ratio has been found to be inversely related to the severity of depression [327].”
BackgroundLiu, X., Zheng, P., Zhao, X., Zhang, Y., Hu, C., Li, J., Zhao, J., Zhou, J., Xie, P., & Xu, G. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00144 · Cited by 193
Ceramides as Novel Disease Biomarkers
Kurz, J., Parnham, M. J., Geißlinger, G., & Schiffmann, S. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.10.009 · Cited by 193
Ishikawa, M., Maekawa, K., Saito, K., Senoo, Y., Urata, M., Murayama, M., Tajima, Y., Kumagai, Y., & Saito, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091806 · Cited by 188
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Dorninger, F., Forss‐Petter, S., & Berger, J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12788 · Cited by 165
Plasma lipidomics reveals potential lipid markers of major depressive disorder
Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9768-5 · Cited by 148
“reported that sphingomyelin (SM) 23:1/SM 16:0 ratio, 1-O-alkyl-2-acyl-PC (PC O)-36:4, and its ratio to ceramide 20:0 were inversely correlated with depressive symptom scores in a Dutch family-based lipidomics study [21].”
The ceramide system as a novel antidepressant target
Kornhuber, J., Müller, C. P., Becker, K. A., Reichel, M., & Gulbins, E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.003 · Cited by 124
Lipids as biomarkers of brain disorders
Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S., Aziz, N., Razzaq, A., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 105
“Most probably, increased Cer level is associated with the severity of depression (Gracia-Garcia et al. 2011; Demirkan et al. 2013) by its possible implication in apoptosis.”
BackgroundInfluentialMahmoudianDehkordi, S., Ahmed, A. T., Bhattacharyya, S., Han, X., Baillie, R. A., Arnold, M., Skime, M. K., John-Williams, L. S., Moseley, M. A., Thompson, J. W., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01097-6 · Cited by 95
Ceramides and depression: A systematic review
Dinoff, A., Herrmann, N., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.008 · Cited by 95
Tkachev, A., Stekolshchikova, E., Vanyushkina, A., Zhang, H., Morozova, A. Y., Zozulya, S. A., Kurochkin, I., Anikanov, N. A., Egorova, A., Yushina, E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4350 · Cited by 77
Lipidomics in Major Depressive Disorder
Walther, A., Cannistraci, C. V., Simons, K., Durán, C., Gerl, M. J., Wehrli, S., & Kirschbaum, C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00459 · Cited by 77
Faria, R., Santana, M. M., Aveleira, C. A., Simões, C. S. O., Maciel, E. A., Melo, T., Santinha, D. R., Oliveira, M. M., Peixoto, F., Domingues, P. M., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.042 · Cited by 80
Metabolomic Biomarkers in Anxiety Disorders
Humer, E. C., Pieh, C., & Probst, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134784 · Cited by 77
“Humans Plasma LC-MS/MS Phosphatidyl-cholines (PC O 36:4), ceramides (CER 20:0) Phospho- and sphingolipid metabolism [41]”
BackgroundDynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities
Javaid, S., Farooq, T., Rehman, Z., Afzal, A., Ashraf, W., Rasool, M. F., Alqahtani, F., Alsanea, S., Alasmari, F. F., Alanazi, M. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111313 · Cited by 69
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Ji, X., Zhang, J., & Jia, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.09.028 · Cited by 63
Sphingolipids in Psychiatric Disorders and Pain Syndromes
Mühle, C., Reichel, M., Gulbins, E., & Kornhuber, J. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-7091-1511-4_22 · Cited by 58
Contribution of ceramides metabolism in psychiatric disorders
Bernal‐Vega, S., García‐Juárez, M., & Camacho‐Morales, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15759 · Cited by 57
“A lipidomic study documented an inverse correlation between anxiety symptoms and sphingomyelin C23:1/sphingomyelin C16:0, or phosphatidylcholine (PC) O- 36:4/ceramide C20:0 ratio levels in plasma (Demirkan et al., 2013).”
BackgroundHuang, T., Balasubramanian, R., Yao, Y., Clish, C. B., Shadyab, A. H., Liu, B., Tworoger, S. S., Rexrode, K. M., Manson, J. E., Kubzansky, L. D., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00870-9 · Cited by 53
Adaptation of Lipid Profiling in Depression Disease and Treatment: A Critical Review
Pinto, B., Conde, T., Domingues, I., & Domingues, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042032 · Cited by 51
“PC-O(36:4); Cer(20:0); SM(16:0); SM(23:1) [69]”
Kim, E. Y., Lee, J. W., Lee, M. Y., Kim, S. H., Mok, H. J., Ha, K., Ahn, Y. M., & Kim, K. P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.029 · Cited by 51
Schumacher, F., Edwards, M. J., Mühle, C., Carpinteiro, A., Wilson, G. C., Wilker, B., Soddemann, M., Keitsch, S., Scherbaum, N., Müller, B. W., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102185 · Cited by 52
Mazereeuw, G., Herrmann, N., Bennett, S. A. L., Swardfager, W., Xu, H., Valenzuela, N., Fai, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.010 · Cited by 47
Buchenauer, L., Haange, S., Bauer, M., Rolle-Kampczyk, U. E., Wagner, M., Stucke, J., Elter, E., Fink, B., Vass, M., von Bergen�, M., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167034 · Cited by 44
Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders
Sethi, S., Hayashi, M. A. F., Sussulini, A., Tasić, L., & Brietzke, E. M. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117656 · Cited by 46
“A Dutch familybased lipidomics study has revealed that the absolute level of phosphatidylcholine (PC-O 36:4) in plasma is associated with depression and anxiety symptoms (Demirkan et al. 2013).”
BackgroundKnowles, E. E. M., Huynh, K., Meikle, P. J., Göring, H. H. H., Olvera, R. L., Mathias, S. R., Duggirala, R., Almasy, L. A., Blangero, J., Curran, J. E., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.02.479 · Cited by 44
“(and sphingomyelin) concentrations are associated with symptoms of depression [33].”
BackgroundWalther, A., Mackens-Kiani, A., Eder, J., Herbig, M., Herold, C., Kirschbaum, C., Guck, J. R., Wittwer, L. D., Beesdo‐Baum, K., & Kräter, M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01911-3 · Cited by 42
Wang, C., Lin, H., Yang, N., Wang, H., Zhao, Y. H., Li, P., Liu, J., & Wang, F. (2019) · Molecules · doi:10.3390/molecules24091712 · Cited by 41
Can targeted metabolomics predict depression recovery? Results from the CO-MED trial
Czysz, A. H., South, C. C., Gadad, B. S., Arning, E., Soyombo, A. A., Bottiglieri, T., & Trivedi, M. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0349-6 · Cited by 40
Filho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 41
“In accordance, increased PLA2 activity in the brain white matter was also reported in samples from MS patients and monkeys submitted to a demyelination model induced by B12 deficiency (Ansell and Spanner, 1968).”
InfluentialLipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36
“↓ SPM 23:1 (anxiety symptoms) [63].”
BackgroundInfluentialMühle, C., Wagner, C., Färber, K., Richter‐Schmidinger, T., Gulbins, E., Lenz, B., & Kornhuber, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060846 · Cited by 38
Miao, G., Deen, J. F., Struzeski, J. B., Chen, M., Zhang, Y., Cole, S. A., Fretts, A. M., Lee, E. T., Howard, B. V., Fiehn, O., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01948-w · Cited by 40
Sphingolipids as Biomarkers of Disease
Matanes, F., Twal, W. O., & Hammad, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_7 · Cited by 35
Mazi, T. A., Sarode, G. V., Członkowska, A., Litwin, T., Kim, K., Shibata, N. M., & Medici, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235937 · Cited by 34
Lipid and energy metabolism in Wilson disease
Mazi, T. A., Shibata, N. M., & Medici, V. (2020) · Liver Research · doi:10.1016/j.livres.2020.02.002 · Cited by 35
Wu, L. M., Han, Y., Zheng, Z., Zhu, S., Chen, J., Yao, Y., Yue, S., Teufel, A., Weng, H., Li, L., et al. (2021) · Nutrients · doi:10.3390/nu13030940 · Cited by 36
“In line with our findings in the MDs-related anxiety mice, experimental research showed the elevated PC in plasma of mice with anxiety disorders [68], and a Dutch family-based lipidomics study presented the association between plasma PC concentrations and anxiety symptoms [69].”
ResultLipidomic analyses in epidemiology
Mundra, P. A., Shaw, J. E., & Meikle, P. J. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw112 · Cited by 34
Ge, Z., Hu, Y., Kan, W., Li, L., Xu, J., Zhang, Y., Zheng, N., Wang, G., & Du, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625087 · Cited by 35
Xue, S., Zhou, C., Xue, F., Liu, L., Cai, Y., Luo, J., Wang, Y., Tan, Q., Wang, H., & Peng, Z. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109946 · Cited by 32
Weng, R., Shen, S., Burton, C., Yang, L., Nie, H., Tian, Y., Bai, Y., & Liu, H. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9256-3 · Cited by 31
Žáček, P., Bukowski, M. R., Rosenberger, T. A., & Picklo, M. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.d070656 · Cited by 32
Xu, M., Legradi, J., & Leonards, P. E. G. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02661-1 · Cited by 30
Zoicas, I., Mühle, C., Schmidtner, A. K., Gulbins, E., Neumann, I. D., & Kornhuber, J. (2020) · Cells · doi:10.3390/cells9051239 · Cited by 29
“In contrast, plasma sphingomyelin SM26:1 [19], SM39:1 and SM39:2 [20] levels were decreased in MDD patients, and the SM23:1/SM16:0 ratio was negatively correlated with the severity of depression symptoms in a Dutch family-based lipidomics study [21].”
ResultSchoeny, H., Rampler, E., Abiead, Y. E., Hildebrand, F., Zach, O., Hermann, G., & Koellensperger, G. (2021) · The Analyst · doi:10.1039/d0an02443k · Cited by 29
Sphingolipids in Major Depression
Jernigan, P. L., Hoehn, R. S., Grassmé, H., Edwards, M. J., Müller, C. P., Kornhuber, J., & Gulbins, E. (2015) · Neurosignals · doi:10.1159/000442603 · Cited by 30
Reichel, M., Hönig, S., Liebisch, G., Lüth, A., Kleuser, B., Gulbins, E., Schmitz, G., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.08.005 · Cited by 28
Nonsynonymous Variation in NKPD1 Increases Depressive Symptoms in European Populations
Amin, N., Belonogova, N. M., Jovanova, O., Brouwer, R. W. W., van Rooij, J., van den Hout, M. C. G. N., Svishcheva, G. R., Kraaij, R., Zorkoltseva, I. V., Kirichenko, A. V., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.008 · Cited by 30
Keksel, N., Bussmann, H., Unger, M., Drewe, J., Boonen, G., Häberlein, H., & Franken, S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.013 · Cited by 31
Serum phosphatidylinositol as a biomarker for bipolar disorder liability
Knowles, E. E. M., Meikle, P. J., Huynh, K., Göring, H. H. H., Olvera, R. L., Mathias, S. R., Duggirala, R., Almasy, L. A., Blangero, J., Curran, J. E., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12468 · Cited by 30
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Zhang, J., & Jia, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151158 · Cited by 26
“Furthermore, ceramides could be associated with multiple psychiatric disorders, including schizophrenia, bipolar disorder, depression, and anxiety [9–11].”
Plasma sphingolipids and depressive symptoms in coronary artery disease
Dinoff, A., Saleem, M., Herrmann, N., Mielke, M. M., OH, P. I., Venkata, S. L. V., Haughey, N. J., & Lanctôt, K. L. (2017) · Brain and Behavior · doi:10.1002/brb3.836 · Cited by 27
“found an association between ceramide C18:0 and depressive symptom severity in their study population (Demirkan et al., 2013).”
BackgroundResultInfluentialPujol-Lereis, L. M., Liebisch, G., Schick, T., Lin, Y.-C., Graßmann, F., Uchida, K., Zipfel, P. F., Fauser, S., Skerka, C., & Weber, B. H. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200739 · Cited by 27
Zoicas, I., Schumacher, F., Kleuser, B., Reichel, M., Gulbins, E., Fejtová, A., Kornhuber, J., & Rhein, C. (2020) · Cells · doi:10.3390/cells9051244 · Cited by 25
“In contrast, plasma sphingomyelin SM26:1 [12], SM21:0 and SM21:1 [13] levels were decreased in MDD patients, and the SM23:1/SM16:0 ratio was negatively correlated with the severity of depressive symptoms in a Dutch family [14].”
ResultAbildgaard, A. M., Kern, T., Pedersen, O. B., Hansen, T. F., Lund, S. A., & Wegener, G. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.001 · Cited by 24
Guo, L., Zhang, T., Li, R., Cui, Z.-Q., Du, J., Yang, J.-B., Xue, F., Chen, Y., Tan, Q.-R., & Peng, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.802710 · Cited by 26
“Previous studies also found that plasma SM was negatively correlated with depressive symptoms (42), and lower concentrations of AcCa and PE were also observed in the plasma of BD patients than that of HCs (43–45).”
ResultmRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
Rhein, C., Zoicas, I., Marx, L. M., Zeitler, S., Hepp, T., von Zimmermann, C., Mühle, C., Richter‐Schmidinger, T., Lenz, B., Erim, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115700 · Cited by 22
“Conversely, plasma sphingomyelin SM26:1 [31], SM21:0, and SM21:1 [32] levels are decreased in MDD patients, and the SM23:1/SM16:0 ratio is negatively correlated with the severity of depression symptoms [33].”
BackgroundAlterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
Zhang, T., Guo, L., Li, R., Wang, F., Yang, W., Yang, J.-B., Cui, Z.-Q., Zhou, C., Chen, Y., Yu, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.927817 · Cited by 23
Singh, R., Sharma, S., Singh, R. K., & Cornélissen, G. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-015-0519-8 · Cited by 23
Role of dietary and nutritional interventions in ceramide-associated diseases
Wang, S., Jin, Z., Wu, B., Morris, A. J., & Deng, P. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100726 · Cited by 22
Ziarrusta, H., Ribbenstedt, A., Mijangos, L., Picart‐Armada, S., Perera-Lluna, A., Prieto, A., Izagirre, U., Benskin, J. P., Olivares, M., Zuloaga, O., et al. (2019) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4381 · Cited by 21
“An inverse correlation between phosphatidylcholines and sphingolipids and neurological disorders (anxiety and depression) has also been found in the literature (Demirkan et al. 2013).”
BackgroundA multi-omics study of circulating phospholipid markers of blood pressure
Liu, J., de Vries, P. S., Fabiola Del Greco, M., Johansson, Å., Schraut, K. E., Hayward, C., van Dijk, K. W., Franco, O. H., Hicks, A. A., Vitart, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04446-7 · Cited by 21
Khan, A., Pan, J. H., Cho, S., Lee, S., Kim, Y. J., & Park, Y. H. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3874 · Cited by 20
“Previous studies performed on the importance of PC have demonstrated several important roles of PC, such as PC makes acetylcholine in human brain,(39) and has been shown to be interrelated with several brain-centered conditions such as dementia,(40) Alzheimer’s disease,(41) anxiety, and depressive disorders.(42) Heavy…”
Wu, Z., Zhao, P., Long, Z., Li, J., Yang, G., Zhang, Q., Duan, G., & Li, H. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2241-1 · Cited by 20
Homorogan, C., Nitusca, D., Enatescu, V., Schubart, P., Moraru, C., Socaciu, C., & Marian, C. (2021) · Metabolites · doi:10.3390/metabo11070466 · Cited by 19
“It is known that AA alone can modulate membrane polarization and fluidity, thus being directly involved in neural cell function and MDD symptomatology [22,33].”
BackgroundEphraim, E., Brockman, J. A., & Jewell, D. E. (2022) · Biology · doi:10.3390/biology11070976 · Cited by 22
“A Dutch family-based lipidomics study of 742 people found inverse correlations between the ratio of sphingomyelin 23:1/sphingomyelin 16:0 and depression/anxiety symptoms, indicating a role for sphingomyelins in these disorders [53].”
BackgroundLanctôt, K. L., Mazereeuw, G., Herrmann, N., Xu, H., Blanchard, A. P., Figeys, D., OH, P. I., & Bennett, S. A. L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s87111 · Cited by 19
“17 These findings are also in line with previously reported associations between PC-derived lipid mediators and depressive symptoms 29 or depressive symptom-like behavior.”
Wang, F., Guo, L., Zhang, T., Cui, Z., Wang, J., Zhang, C., Xue, F., Zhou, C., Li, B., Tan, Q., et al. (2022) · Medicina · doi:10.3390/medicina58111509 · Cited by 18
“Supporting these findings, previous studies found that levels of PE were decreased in the serum and postmortem prefrontal white matter in SCZ patients [31,32], and serum PE was also negatively correlated with depressive symptoms [33].”
ResultHong, L., Wang, H., Leijie, X., Dandan, Z., Liu, P., Hu, Z., Ma, R., Yijun, S., Guanghui, Z., & Guojun, Z. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.03.014 · Cited by 19
Lokhov, P. G., Maslov, D. L., Balashova, E. E., Trifonova, O. P., Medvedeva, N. V., Torkhovskaya, T. I., Ipatova, O. M., Archakov, A. I., Прокопьевич, М. П., Kukharchuk, V. V., et al. (2015) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20156101007 · Cited by 17
Song, Y., Lai, M., Liao, Z., Zhang, Z., Zhu, G., Yang, M., Ai, Z., Zheng, Q., & Su, D. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155829 · Cited by 17
Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals
Graessler, J., Mehnert, C. S., Schulte, K., Bergmann, S., Strauss, S., Bornstein, T. D., Licinio, J., Wong, M., Birkenfeld, A. L., & Bornstein, S. R. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.24 · Cited by 16
Screening for depression in the general population through lipid biomarkers
Tkachev, A., Stekolshchikova, E., Golubova, A., Serkina, A., Morozova, A. Y., Zorkina, Y., Riabinina, D., Golubeva, E., Ochneva, A., Savenkova, V., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105455 · Cited by 15
Application of fatty acid and lipid measurements in neuropsychiatry
Grela, A., Rachel, W., Cole, M., Zyss, T., Zięba, A., & Piekoszewski, W. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0394 · Cited by 14
“A lipidomic study on a Dutch population was performed [89] and two lipids were found to be highly correlated with depressive symptoms (assessed by the Hospital Anxiety and Depression Scales): 1) PC O 36:4 (1-O-hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine; an ether phospholipid that contains a bound AA (C20:4,…”
MethodChen, G., Zhou, S., Chen, Q., Liu, M., Dong, M.-X., Hou, J., & Zhou, B. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.965697 · Cited by 14
“Clinical research indicated that plasma PC concentrations of depression patients were associated with the severity of depression (Demirkan et al., 2013).”
BackgroundWang, Y., Chen, H., Wang, J., Chen, S., Liu, J., Chen, X., Li, S., Tang, H., Zhou, J., Ye, Y., et al. (2025) · Depression and Anxiety · doi:10.1155/da/5564796 · Cited by 15
“Absolute levels of PC O 36:4 were also negatively correlated with depressive symptoms in an independent validation with 753 individuals [42].”
Chang, C., Wu, H.-C., Hsieh, Y.-R., Lai, W.-D., Tung, T.-H., Huang, J.-J., Kao, W., & Huang, S. (2023) · Food & Function · doi:10.1039/d3fo01452e · Cited by 13
Hernández-Baixauli, J., Puigbò, P., Abasolo-Zabalo, N., Palacios, H. H., Foguet‐Romero, E., Suñol, D., Galofré, M., Caimari, A., Baselga‐Escudero, L., Bas-Prior, J. M. D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312931 · Cited by 12
Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia
Tkachev, A., Stekolshchikova, E., Anikanov, N., Zozulya, S., Barkhatova, A., Klyushnik, T., & Petrova, D. (2021) · Biomolecules · doi:10.3390/biom11050720 · Cited by 11
He, L., Duan, N., Wang, C., Shan, R., Li, J., Wang, L., Liu, Q., Tao, J., Liu, L., Ma, X., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07191-7 · Cited by 11
“Thus, phospho-and sphingolipid molecules can be considered as potential biomarkers of MDD, possibly related to the linoleic/arachidonic acid inflammation pathway [12, 13].”
SGMS2 in primary osteoporosis with facial nerve palsy
Pihlström, S., Richardt, S., Määttä, K. M., Pekkinen, M., Olkkonen, V. M., Mäkitie, O., & Mäkitie, R. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1224318 · Cited by 11
Kelley, D. P., Chaichi, A., Duplooy, A., Singh, D. P., Gartia, M. R., & Francis, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100476 · Cited by 11
“ROS and OXS is have a substantial impact on cellular viability of all neural cell types, but oligodendrocytes, cells that form myelin-sheaths and contribute up to 80% of the brain ’ s total cholesterol are particularly sensitive (Chao et al., 2015; Dietschy, 2009; Schiavone et al., 2013).”
BackgroundMetabolomic profiles in night shift workers: A cross-sectional study on hospital female nurses
Borroni, E., Frigerio, G., Polledri, E., Mercadante, R., Maggioni, C., Fedrizzi, L., Pesatori, A. C., Fustinoni, S., & Carugno, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1082074 · Cited by 11
“Lower levels of sphingolipids were found in patients with a diagnosis of major depressive disorder: Demirkan and colleagues identified significant negative associations between the sphingomyelin (SM) ratio 23:1 to SM 16:0 and a psychometric depression measure (Center for Epidemiological Studies-Depression Scale: CES-D…”
BackgroundXie, J., Li, Y., Liang, Y., Kui, H., Wang, C., & Huang, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116571 · Cited by 11
Mazereeuw, G., Herrmann, N., David, W. L., Hillyer, L. M., OH, P. I., & Lanctôt, K. L. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.009 · Cited by 11
“A recent study implicated sphingomyelin species, such as SM 23:1 and SM 16:0, as correlates of depressive symptoms (Demirkan et al., 2013); however, that study was unable to characterize the fatty acid chains involved, which is a limitation that may have been overcome by the present study.”
Danyang, L., Yang, J., Jin, W., Zhong, Q., & Zhou, T. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03349-w · Cited by 12
Gary, A. A., Prislovsky, A., Tovar, A., Locatelli, E. V. T., Felix, E. R., Stephenson, D., Chalfant, C. E., Lai, J. M., Kim, C. K., Mandal, N. A., et al. (2023) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14343 · Cited by 10
Altered lipidomics biosignatures in schizophrenia: A systematic review
Messinis, A., Panteli, E., Paraskevopoulou, A., Zymarikopoulou, A.-K., & Filiou, M. D. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.043 · Cited by 11
Saito, K., Ishikawa, M., Murayama, M., Urata, M., Senoo, Y., Toyoshima, K., Kumagai, Y., Maekawa, K., & Saito, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112266 · Cited by 10
Zhou, C., Xue, F., Shi, Q., Xue, S., Zhang, T., Ma, X., Yu, L., Liu, C., Wang, H., & Peng, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.812479 · Cited by 9
Maehashi, S., Arora, K., Fisher, A. L., Schweitzer, D. R., & Akefe, I. O. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105741 · Cited by 11
“Rodent model studies have demonstrated that prolonged exposure to stress may lead to an altered composition and function of these neuro-lipids within the central nervous system (Demirkan et al., 2013; Hursi-to ˘ glu and Kurutas, 2023; Bulut et al., 2013).”
InfluentialKurkinen, K., Kärkkäinen, O. K., Lehto, S. M., Luoma, I., Kraav, S., Nieminen, A. I., Kivimäki, P., Therman, S., & Tolmunen, T. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100261 · Cited by 10
Donato, P., Cacciola, F., Beccaria, M., Dugo, P., & Mondello, L. (2015) · Comprehensive analytical chemistry · doi:10.1016/b978-0-444-63340-8.00008-x · Cited by 10
Bisle, E., Haange, S., Rojas, R., Behnke, A., Karabatsiakis, A., Gumpp, A. M., Mack, M., Mavioğlu, R. N., Lutz‐Bonengel, S., Rolle-Kampczyk, U. E., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116569 · Cited by 10
“However, other studies report reduced vinyl ether glycerophospholipids in the blood of patients and rat brains under chronic stress (Demirkan et al., 2013; X. Liu et al., 2016; Oliveira et al., 2016; Tkachev et al., 2023).”
Metadata
- Authors
- Demirkan, A., Isaacs, A., Ugocsai, P., Liebisch, G., Struchalin, M., Rudan, I., Wilson, J. F., Pramstaller, P. P., Gyllensten, U., Campbell, H., Schmitz, G., Oostra, B. A., & van Duijn, C. M.
- Affiliations
- Erasmus MC (NL)
- University Hospital Regensburg (DE)
- University of Split (HR)
- University of Edinburgh (GB)
- Eurac Research (IT)
- Uppsala University (SE)
- Corresponding author
- Isaacs, Aaron
- ORCID
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 47
- Issue
- 3
- Pages
- 357-362
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2164766370
- Cited by
- 163
- References
- 51
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 22 · 2023: 14 · 2022: 15 · 2021: 14 · 2020: 11 · 2019: 10 · 2018: 9 · 2017: 9 · 2016: 12 · 2015: 11 · 2014: 7 · 2013: 3
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- H2020 European Research Council
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, anxiety, phospholipids, sphingolipids, ether phospholipids, polyunsaturated fatty acids, lipid biomarkers, family studies, ceramide
- MeSH terms
- Adult, Aged, Anxiety, Depression, Family Health, Female, Humans, Male, Middle Aged, Netherlands, Phosphatidylcholines, Psychiatric Status Rating Scales, Sphingomyelins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review